1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular characterization of circulating prostatic tumor cells after leukapheresis in prostatic carcinoma patients
    Meeting Abstract

    Bhattacharya, S.; Scher, H.; Osman, I.; Juan, G.; Hutchinson, B.; Cordon-Cardo, C.; Ghossein, R. A.
    Journal of Histochemistry and Cytochemistry (2000)

    Fulltext@MSK | Save
  • 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) inhibits intracellular Akt kinase activity in HER2 overexpressing breast cancer cell lines and enhances the apoptosis induced by cytotoxic agents
    Meeting Abstract

    Munster, P. N.; Basso, A.; Solit, D.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • 17-allyl-amino-seldanamycin induces HER2 degradation and AKT inactivation in a human breast cancer xenograft model
    Meeting Abstract

    Solit, D.; Munster, P.; Basso, A.; Tong, W.; Agus, D.; Scher, H.; Norton, L.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Phase I study of a 40kDa branched pegylated-interferon alpha-2a (PEGASYS (TM)) in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Motzer, R.; Berg, W.; Rakhit, A.; Ginsberg, M.; Rittweger, K.; Fettner, S.; Yu, R.; Hooftman, L.
    Annals of Oncology (2000)

    Fulltext@MSK | Save
  • Cytokine therapy in renal cell cancer
    Journal Article

    Vuky, J.; Motzer, R. J.
    Urologic Oncology: Seminars and Original Investigations (2000)

    Fulltext@MSK | Save
  • Carcinoid tumor of the kidney: The use of somatostatin receptor scintigraphy in diagnosis and management
    Journal Article

    Mccaffrey, J. A.; Reuter, V.; Herr, H. W.; Macapinlac, H. A.; Russo, P.; Motzer, R. J.
    Urologic Oncology: Seminars and Original Investigations (2000)

    Fulltext@MSK | Save
  • A potential role for activated HER-2 in prostate cancer
    Journal Article

    Agus, D. B.; Akita, R. W.; Fox, W. D.; Lofgren, J. A.; Higgins, B.; Maiese, K.; Scher, H. I.; Sliwkowski, M. X.
    Seminars in Oncology (2000)

    Fulltext@MSK | Save
  • Paclitaxel (Taxol) combination therapy for resistant germ cell tumors
    Journal Article

    Motzer, R. J.
    Seminars in Oncology (2000)

    Fulltext@MSK | Save
  • Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors
    Journal Article

    Morris, M. J.; Bosl, G. J.
    Journal of Urology (2000)

    Fulltext@MSK | Save
  • Prostate cancer: Therapeutic patent review
    Journal Article

    Sepp-Lorenzino, L.; Slovin, S.
    Expert Opinion on Therapeutic Patents (2000)

    Fulltext@MSK | Save